Percutaneous coronary intervention (PCI) via the femoral artery often requires vascular closure devices (VCDs) to minimize complications. This study examines the cost-effectiveness of contemporary Pci Vcds in a large patient population.
PCI, also known as angioplasty, is a common procedure to open blocked heart arteries. When performed through the femoral artery (transfemoral PCI), achieving rapid and effective hemostasis is crucial to prevent complications. Traditionally, manual compression was used, but VCDs offer a potentially safer and more efficient alternative. This comprehensive analysis delves into the economic and clinical impact of using PCI VCDS in a real-world setting.
PCI VCDS Reduce Complications and Hospital Stays
This single-center study analyzed 8,292 transfemoral PCI patients, with 1,780 receiving VCDs. Results showed a significant 53% reduction in vascular complications like false aneurysms and major hematomas in the PCI VCDS group.
Table showing baseline characteristics of patients with and without VCDs in a PCI procedure.
Furthermore, PCI VCDS significantly shortened hospital stays. The average post-PCI stay decreased from 2.8 days to 1.5 days with VCD use, a remarkable 65% reduction. This translates to quicker patient recovery and improved hospital resource utilization.
Table outlining the types and frequency of vascular complications observed in patients undergoing PCI, categorized by VCD use.
Cost Savings with PCI VCDS Across Risk Profiles
The reduced complication rates and shorter hospital stays associated with PCI VCDS led to significant cost savings. The average cost per patient was €498 lower in the VCD group. This finding held true across different patient risk profiles, including those considered high-risk due to age and gender.
Table displaying risk factors associated with vascular complications after PCI.
Graph comparing the length of hospital stay for PCI patients with and without VCDs, stratified by vascular risk.
Graph illustrating the distribution of cost differences between PCI patients with and without VCDs.
While the initial cost of PCI VCDS might seem a deterrent, the overall cost savings from reduced complications and shorter hospital stays demonstrate the long-term economic benefits.
Conclusion: PCI VCDS Offer Compelling Advantages
This study highlights the significant advantages of using PCI VCDS in transfemoral PCI. The reduction in vascular complications, shorter hospital stays, and overall cost savings make a compelling case for their wider adoption. While the radial approach for PCI is gaining popularity, the femoral approach with PCI VCDS remains a viable and cost-effective option, especially for complex cases or patients unsuitable for radial access. The findings emphasize the importance of considering PCI VCDS as a standard practice in transfemoral PCI to improve patient outcomes and optimize healthcare resources.
